|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|
| Revenue from sale of goods | ||||
| Royalties | ||||
| Marketing and Other Contra Revenue Items | ||||
| Revenues, net of royalties | ||||
| Purchases of crude oil and products(1) | ||||
| Production, operating and transportation expenses(1) (note 21) | ||||
| Selling, general and administrative expenses (note 21) | ||||
| Depletion, depreciation, amortization and impairment (notes 9, 10, 11, 12) | ||||
| Exploration and evaluation expenses (note 8) | ||||
| Gain on sale of assets | ||||
| Other – net(1) (notes 14, 25, 26) | ||||
| Operating expense | ||||
| Loss from operating activities | ||||
| Share of equity investment income (note 12) | ||||
| Net foreign exchange gain | ||||
| Finance income | ||||
| Finance expenses | ||||
| Financial Items | ||||
| Loss before income taxes | ||||
| Provisions for (recovery of) income taxes. current | ||||
| Provisions for (recovery of) income taxes, deferred | ||||
| Provisions for (recovery of) income taxes | ||||
| Net loss | ||||
| Loss per share (note 20) | ||||
| Loss per share – basic ($/share) | ||||
| Loss per share – diluted ($/share) | ||||
| Weighted average number of common shares outstanding (note 20) | ||||
| Weighted average number of common shares outstanding, basic | ||||
| Weighted average number of common shares outstanding, diluted |
Loading...
